Gallant

FELINE CHRONIC GINGIVOSTOMATITIS (FCGS) STUDY

Hope for cats with no alternative options

This is potentially the first drug targeting the disease process

Do you have a cat that has been diagnosed with stomatitis or is showing any of these signs:

  • Licking excessively
  • Drooling
  • Not wanting to groom
  • Vocalization
  • Bleeding gums
  • Sores in the mouth

If so, your cat may have Feline Chronic Gingivostomatitis (FCGS), also called gingivostomatitis and caudal stomatitis. The disease causes painful lesions in your cat's mouth that markedly impacts their quality of life and wellbeing. If your cat has already undergone medical treatment and extraction of their teeth and are still showing clinical signs of disease and lesions in the mouth they are considered refractory and have limited to no currently available treatment options.

Why should my cat be considered for this study?

  • Your cat will receive specialty veterinary care throughout the study, including physical exams, blood work, and urinalysis at NO OUT OF POCKET cost to you.
  • Your cat may play an important role in advancing feline medicine.

This study may be used to support a new animal drug application to be submitted to the Food and Drug Administration.

Why Stem Cells?

Stem cells are naturally occurring cells that exist in adult tissues and have regenerative properties (help tissues repair and heal). They have the ability to modify the immune system and target the underlying disease process.

The stem cells used in this product are derived from a healthy donor cat’s uterus that is collected during a routine spay procedure. Rather than the uterus being discarded as normal after surgery, it is packaged in a sterile manner and shipped to the manufacturing facility. The donor cat recovery follows a normal spay procedure.

The mesenchymal stem cells are harvested, cultured, expanded, and frozen at ultra cold temperatures to provide a source of live cells once thawed at the time of treatment. These stem cells have the ability to immunomodulate (regulation of the immune system to be adaptive) through cellular signaling. This provides a natural and targeted mechanism for treatment of disease.

Interested in Participating in the Clinical Trial?